Williams, J.
We are presented with three issues. First is whether there is a delivery under the Michigan Controlled Substances Act (1971 PA 196, MCL 335.341; MSA 18.1070[41] when a physician gives a prescription or dispenses a box of pills. Second is whether a licensed physician can be prosecuted under MCL 335.341(1)(b); MSA 18.1070(41)(1)(b), for unlawful delivery of a controlled substance. The third is whether as a matter of law the defense of entrapment was established.
The appellant, Dr. Alford, was charged with two counts of unlawful delivery of a controlled substance. The first count was for giving prescriptions for 120 capsules containing amphetamines to an undercover police officer in the names of persons never examined by the doctor. The second count was for actually giving 103 capsules containing barbiturates to the same undercover police officer.
The trial court granted a pretrial motion to quash the information finding (1) physicians dispensing and/or prescribing controlled substances are not subject to prosecution under MCL 335.341(l)(b); MSA 18.1070(41)(1)(b) and (2) the appellant was entrapped as a matter of law. The Court of Appeals reversed on both grounds, People v Alford, 73 Mich App 604; 251 NW2d 314 (1977).
In People v Kerwin, 56 Mich App 483; 224 NW2d 113 (1974), a panel of the Court of Appeals held physicians were not subject to prosecution under MCL 335.341(1)(b); MSA 18.1070(41)(1)(b). The opposite conclusion was reached by the Court in Alford.
[579]*579We granted leave to appeal August 31, 1977, 401 Mich 804 (1977), to resolve a conflict in the Court of Appeals.
We agree with the holding of the Court of Appeals in Alford. Physicians not acting in good faith "in the course of professional practice or research” are prosecutable under MCL 335.341(1); MSA 18.1070(41)(1). We also agree with their determination that the defense of entrapment was not established as a matter of law.
We affirm the Court of Appeals in Alford.
I. Facts
On March 12, 1973, Justin Kukalis, an officer of the Department of State Police, Intelligence Division, Diversion Investigation Unit, visited Dr. Alford at his office. Kukalis posed as a patient and gave the name James Kase. He complained of being overweight. The doctor weighed him and took his blood pressure by placing the blood pressure cuff over his jacket on his arm. The doctor gave him medication1 (92 small white and 30 small flat pink double-scored tablets) and a prescription for 30 amphetamine capsules. He did not tell him what the medication was, but gave him directions on dosage, one tablet a day. The doctor told him to return in two weeks. Officer Kukalis paid for the visit.2
As noted by the trial court:
"Kukalis returned on approximately eight or nine occasions thereafter, and on these occasions he was not [580]*580given a further medical examination, although on some of the return visits he was weighed and on others he was asked about his weight.
"On these occasions when Kukalis returned to Dr. Alford’s office, Dr. Alford usually handed Kukalis drugs containing amphetamines. On some occasions he handed Kukalis drugs containing barbiturates, and on some of these occasions he wrote prescriptions for Kukalis for amphetamine drugs.”
On June 1, 1973, Kukalis went to the doctor’s office. The doctor informed Kukalis he had no amphetamines available and that he did not like writing prescriptions so often. The doctor then wrote a prescription for Kukalis for 30 amphetamine capsules. The doctor asked who else needed a prescription. Kukalis supplied the names and addresses of fictitious people, Neil Harris and Karen Kase. The doctor wrote prescriptions for them. Kukalis then supplied the name Donald Hollis and the doctor supplied an address as he wrote the prescription. Kukalis also requested and received a small white box of red capsules, 59, and some blue and clear capsules, 43.
The four prescriptions received by Kukalis from Dr. Alford on June 1, 1973 were filled by a drug inspector in the Department of Licensing and Regulation assigned to the Diversion Investigation Unit. The drug inspector was a pharmacist. The contents of each prescription were analyzed by the Michigan State Police Scientific Laboratory. Each prescription was for amphetamine sulphate, 30 capsules, a schedule 2 controlled substance.
The medication directly received by Kukalis on June 1, 1973 was also analyzed by the Michigan State Police Scientific Laboratory. The 59 orange capsules contained secobarbital, a schedule 3 controlled substance. The 44 blue and clear capsules [581]*581contained amobarbital, also a schedule 3 controlled substance.
Based on the drugs received on June 1, 1973, a two-count information was filed against Dr. Alford charging that he (1) "did unlawfully deliver a controlled substance, to-wit: 120 capsules containing amphetamine, contrary to the provisions of MCL 335.341(l)(b);” and (2) "did unlawfully deliver a controlled substance, to-wit: 103 capsules containing barbituates [sic], contrary to the provisions of MCL 335.341(1)(b)”.
After the preliminary examination the defendant was bound over for trial on both counts. The defendant filed a motion to quash the information which was granted by the trial court. The judge held that writing prescriptions was not a delivery or constructive delivery within the meaning of MCL 335.341(l)(b); MSA 18.1070(41)(1)(b). The judge also held:
"that this statute either frees licensed physicians, without qualification, to hand out barbiturate drugs, or it permits them to hand out such drugs to people who come, to their offices for professional consultation regardless of whether the physicians’ conduct falls short of the standards of skill, care and ethics customarily employed by their co-professionals.”
In conclusion the judge found:
"as a matter of law, that the defendant was entrapped.”
The Court of Appeals reversed the decision of the trial court holding
"that a practitioner is not exempt from prosecution under MCL 335.341(1); MSA 18.1070(41)(1), merely because of his registered status. The practitioner’s activi[582]*582ties are only protected to the extent they are performed within the course of professional practice.” 73 Mich App 604, 614.
The Court also found that
"[t]he facts in the case at bar do not indicate the government conduct was of such a nature as to give rise to a finding of entrapment.” 73 Mich App 604, 615.
II. Applicable Portions of the Controlled Substances Act of 1971
MCL 335.341; MSA 18.1070(41) establishes the basic penalties for violation of the Controlled Substances Act of 1971 and provides in pertinent part:
"(1) Except as authorized by this act, it is unlawful for any person to manufacture, deliver or possess with intent to manufacture or deliver, a controlled substance. Any person who violates this subsection with respect to:
Free access — add to your briefcase to read the full text and ask questions with AI
Williams, J.
We are presented with three issues. First is whether there is a delivery under the Michigan Controlled Substances Act (1971 PA 196, MCL 335.341; MSA 18.1070[41] when a physician gives a prescription or dispenses a box of pills. Second is whether a licensed physician can be prosecuted under MCL 335.341(1)(b); MSA 18.1070(41)(1)(b), for unlawful delivery of a controlled substance. The third is whether as a matter of law the defense of entrapment was established.
The appellant, Dr. Alford, was charged with two counts of unlawful delivery of a controlled substance. The first count was for giving prescriptions for 120 capsules containing amphetamines to an undercover police officer in the names of persons never examined by the doctor. The second count was for actually giving 103 capsules containing barbiturates to the same undercover police officer.
The trial court granted a pretrial motion to quash the information finding (1) physicians dispensing and/or prescribing controlled substances are not subject to prosecution under MCL 335.341(l)(b); MSA 18.1070(41)(1)(b) and (2) the appellant was entrapped as a matter of law. The Court of Appeals reversed on both grounds, People v Alford, 73 Mich App 604; 251 NW2d 314 (1977).
In People v Kerwin, 56 Mich App 483; 224 NW2d 113 (1974), a panel of the Court of Appeals held physicians were not subject to prosecution under MCL 335.341(1)(b); MSA 18.1070(41)(1)(b). The opposite conclusion was reached by the Court in Alford.
[579]*579We granted leave to appeal August 31, 1977, 401 Mich 804 (1977), to resolve a conflict in the Court of Appeals.
We agree with the holding of the Court of Appeals in Alford. Physicians not acting in good faith "in the course of professional practice or research” are prosecutable under MCL 335.341(1); MSA 18.1070(41)(1). We also agree with their determination that the defense of entrapment was not established as a matter of law.
We affirm the Court of Appeals in Alford.
I. Facts
On March 12, 1973, Justin Kukalis, an officer of the Department of State Police, Intelligence Division, Diversion Investigation Unit, visited Dr. Alford at his office. Kukalis posed as a patient and gave the name James Kase. He complained of being overweight. The doctor weighed him and took his blood pressure by placing the blood pressure cuff over his jacket on his arm. The doctor gave him medication1 (92 small white and 30 small flat pink double-scored tablets) and a prescription for 30 amphetamine capsules. He did not tell him what the medication was, but gave him directions on dosage, one tablet a day. The doctor told him to return in two weeks. Officer Kukalis paid for the visit.2
As noted by the trial court:
"Kukalis returned on approximately eight or nine occasions thereafter, and on these occasions he was not [580]*580given a further medical examination, although on some of the return visits he was weighed and on others he was asked about his weight.
"On these occasions when Kukalis returned to Dr. Alford’s office, Dr. Alford usually handed Kukalis drugs containing amphetamines. On some occasions he handed Kukalis drugs containing barbiturates, and on some of these occasions he wrote prescriptions for Kukalis for amphetamine drugs.”
On June 1, 1973, Kukalis went to the doctor’s office. The doctor informed Kukalis he had no amphetamines available and that he did not like writing prescriptions so often. The doctor then wrote a prescription for Kukalis for 30 amphetamine capsules. The doctor asked who else needed a prescription. Kukalis supplied the names and addresses of fictitious people, Neil Harris and Karen Kase. The doctor wrote prescriptions for them. Kukalis then supplied the name Donald Hollis and the doctor supplied an address as he wrote the prescription. Kukalis also requested and received a small white box of red capsules, 59, and some blue and clear capsules, 43.
The four prescriptions received by Kukalis from Dr. Alford on June 1, 1973 were filled by a drug inspector in the Department of Licensing and Regulation assigned to the Diversion Investigation Unit. The drug inspector was a pharmacist. The contents of each prescription were analyzed by the Michigan State Police Scientific Laboratory. Each prescription was for amphetamine sulphate, 30 capsules, a schedule 2 controlled substance.
The medication directly received by Kukalis on June 1, 1973 was also analyzed by the Michigan State Police Scientific Laboratory. The 59 orange capsules contained secobarbital, a schedule 3 controlled substance. The 44 blue and clear capsules [581]*581contained amobarbital, also a schedule 3 controlled substance.
Based on the drugs received on June 1, 1973, a two-count information was filed against Dr. Alford charging that he (1) "did unlawfully deliver a controlled substance, to-wit: 120 capsules containing amphetamine, contrary to the provisions of MCL 335.341(l)(b);” and (2) "did unlawfully deliver a controlled substance, to-wit: 103 capsules containing barbituates [sic], contrary to the provisions of MCL 335.341(1)(b)”.
After the preliminary examination the defendant was bound over for trial on both counts. The defendant filed a motion to quash the information which was granted by the trial court. The judge held that writing prescriptions was not a delivery or constructive delivery within the meaning of MCL 335.341(l)(b); MSA 18.1070(41)(1)(b). The judge also held:
"that this statute either frees licensed physicians, without qualification, to hand out barbiturate drugs, or it permits them to hand out such drugs to people who come, to their offices for professional consultation regardless of whether the physicians’ conduct falls short of the standards of skill, care and ethics customarily employed by their co-professionals.”
In conclusion the judge found:
"as a matter of law, that the defendant was entrapped.”
The Court of Appeals reversed the decision of the trial court holding
"that a practitioner is not exempt from prosecution under MCL 335.341(1); MSA 18.1070(41)(1), merely because of his registered status. The practitioner’s activi[582]*582ties are only protected to the extent they are performed within the course of professional practice.” 73 Mich App 604, 614.
The Court also found that
"[t]he facts in the case at bar do not indicate the government conduct was of such a nature as to give rise to a finding of entrapment.” 73 Mich App 604, 615.
II. Applicable Portions of the Controlled Substances Act of 1971
MCL 335.341; MSA 18.1070(41) establishes the basic penalties for violation of the Controlled Substances Act of 1971 and provides in pertinent part:
"(1) Except as authorized by this act, it is unlawful for any person to manufacture, deliver or possess with intent to manufacture or deliver, a controlled substance. Any person who violates this subsection with respect to:
"(b) Any other controlled substance classified in schedules 1, 2 or 3, except marihuana, is guilty of a felony and upon conviction may be imprisoned for not more than 7 years or fined not more than $5,000.00, or both.”3
Specific definitions are provided for the terms used in this section:
[583]*583" 'Person’ means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.” MCL 335.307(1); MSA 18.1070(7)(1).
" 'Deliver’ or 'delivery’ means the actual, constructive or attempted transfer from 1 person to another of a controlled substance, whether or not there is an agency relationship.” MCL 335.304(1); MSA 18.1070(4)(1).
These provisions must be considered in light of other sections relating to physicians:
" 'Practitioner’ means:
"(a) A physician, dentist, veterinarian or pharmacist as defined in subdivisions (o), (p), (q) and (w) of section 1 of Act No. 151 of the Public Acts of 1962, as amended, being section 338.1101 of the Compiled Laws of 1948, scientific investigator as defined by rule of the administrator, or other person licensed, registered or otherwise permitted to distribute, dispense, conduct research with respect to or to administer a controlled substance in the course of professional practice or research in this state.” (Emphasis added.) MCL 335.307(3); MSA 18.1070(7)(3).
" 'Dispense’ means to deliver or issue a controlled substance to an ultimate user or research subject by or pursuant to the lawful order of a practitioner, including the prescribing, administering or compounding necessary to prepare the substance for that delivery or issuance.” MCL 335.304(2); MSA 18.1070(4X2).
"(1) Every person who manufactures, distributes, prescribes or dispenses any controlled substance within this state or who proposes to engage in the manufacture, distribution, prescribing or dispensing of any controlled substance within this state, shall obtain annually a registration issued by the administrator in accordance with its rules.
"(2) Persons registered by the administrator under this act to manufacture, distribute, prescribe, dispense or conduct research with controlled substances may possess, manufacture, distribute, prescribe, dispense or [584]*584conduct research with those substances to the extent authorized by their registration and in conformity with the other provisions of this chapter.” MCL 335.332; MSA 18.1070(32).
These sections provide the focal point of our analysis.
III. "Delivery” Under the Act
Counts 1 and 2 charged defendant "did unlawfully deliver a controlled substance”. For Count 1, the proofs were that defendant wrote prescriptions for Officer Kukalis and for three fictitious people, with the defendant supplying a fictitious address for the last one. For Count 2, the proofs were that defendant handed or dispensed to Officer Kukalis a box of pills. %
Therefore two questions relating to delivery exist: A. Is prescribing delivery? B. Is handing/dispensing delivery?
A. Prescribing
MCL 335.304(1); MSA 18.1070(4X1), as noted above, reads in part: " 'Deliver’ * * * means the actual, constructive or attempted transfer * * * of a controlled substance”. MCL 335.304(2); MSA 18.1070(4)(2), as noted above, reads in part: " 'Dispense’ means to deliver * * * by or pursuant to the lawful order of a practitioner, including the prescribing * * As a consequence, prescribing is included in the definition of deliver.
B. Handing/Dispensing
The two statutory definitions examined in A. Prescribing also demonstrate that handing or dis[585]*585pensing pills is included within the definition of "deliver”.
IV. Application to Physicians
The statute prohibits "any person” from delivering a controlled substance. This blanket prohibition by itself would prevent physicians from dispensing any medication.
The statutory restriction on the delivery of controlled substances is clear. The term "person” as defined by the statute4 does not exclude physicians or any other group. We find this categorical approach consistent with the legislative desire to establish the most comprehensive system of controls to regulate the use and abuse of controlled substances.
Physicians, however, do possess a limited exemption from prosecution in MCL 335.332(2); MSA 18.1070(32)(2) which states:
"Persons registered by the administrator under this act to manufacture, distribute, prescribe, dispense or conduct research with controlled substances may possess, manufacture, distribute, prescribe, dispense or conduct research with those substances to the extent authorized by their registration and in conformity with the other provisions of this chapter.”
To maintain their exemption they must be in compliance with their registration under the act and conform to the other provisions of the act.
But MCL 335.307(3)(a); MSA 18.1070(7)(3)(a) provides a limitation on their license to dispense controlled substances. This section defines a "practitioner” to include:
[586]*586"A physician, * * * or other person licensed, registered or otherwise permitted to distribute, dispense, conduct research with respect to or to administer a controlled substance in the course of professional practice or research in this state.” (Emphasis added.)
Therefore physicians must act "in the course of professional practice or research” to retain their limited exemption.
We find support for our interpretation of the Controlled Substances Act of 1971 in United States v Moore, 423 US 122; 96 S Ct 335; 46 L Ed 2d 333 (1975). In Moore a licensed physician registered under the Federal Controlled Substances Act, 21 USC 801 et seq., was convicted of a violation of 21 USC 841(a)(1) which made it:
"unlawful for any person knowingly or intentionally— * * * to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense, a controlled substance;”.5
Our act substantially parallels the Federal Controlled Substances Act, 21 USC 801 et seq.6
[587]*587The United States Supreme Court extensively analyzed the Federal Controlled Substances Act and its legislative history and held:
"that registered physicians can be prosecuted under § 841 when their activities fall , outside the usual course of professional practice.” 423 US 122, 124.
An interesting question raised by defendant is whether he can be prosecuted under MCL 335.341; MSA 18.1070(41) in light of MCL 335.342; MSA 18.1070(42) which provides:
"(1) It is unlawful for any person:
"(a) Who is subject to chapter 3, to distribute, prescribe or dispense a controlled substance in violation of section 38.
"(b) Who is a registrant, to manufacture a controlled substance not authorized by his registration, or to distribute, prescribe or dispense a controlled substance not authorized by his registration to another registrant or other authorized person, except as authorized by rules promulgated by the administrator.
"(2) Any person who violates this section may be punished by a civil fine of not more than $25,000.00 in a proceeding in the circuit court. However, if the violation is prosecuted by a criminal indictment which alleges that the violation was committed knowingly or intentionally, and the trier of the fact specifically finds that the violation was committed knowingly or intentionally, such person is guilty of a misdemeanor and upon conviction may be imprisoned for not more than 2 years or fined not more than $25,000.00, or both.”
Defendant contends that MCL 335.342; MSA 18.1070(42) establishes a separate and distinct penal system for persons registered under the act.
This very point was considered in Moore because 21 USC 842 is comparable to MCL 335.342; MSA [588]*58818.1070(42). Moore was decided adversely to defendant.
"Respondent nonetheless contends that §§ 841 and 822(b) must be interpreted in light of a congressional intent to set up two separate and distinct penalty systems: Persons not registered under the Act are to be punished under § 841, while those who are registered are to be subject only to the sanctions of §§ 842 and 843. The latter two sections, the argument goes, establish modest penalties which are the sole sanctions in a system of strict administrative regulation of registrants.
"The operative language of those sections provides no real support for the proposition that Congress intended to establish two mutually exclusive systems. It is true that the term 'registrants’ is used in §§842 and 843, and not in § 841. But this is of limited significance. All three sections provide that '[i]t shall be unlawful for any person * * * [to commit the proscribed acts].’ Two of the eight subsections of § 842(a), one of the five subsections of § 843(a) and § 842(b) further qualify 'any person’ with 'who is a registrant.’ The other subsections of §§ 842 and 843 are not so limited. In context, 'registrant’ is merely a limiting term, indicating that the only 'persons’ who are subject to these subsections are 'registrants.’ There is no indication that 'persons’ means 'nonregistrants’ when introducing the other subsections.” 423 US 122, 133-134.
The United States Supreme Court decision in Moore has been used by two jurisdictions to support a finding that physicians are subject to prosecution for violations similar to those in the instant case.
In State v Vaccaro, 142 NJ Super 167, 173; 361 A2d 47 (1976), the Court stated:
"A physician who is honest and ethical, and dispenses the prohibited drugs in a good faith effort to treat and cure patients, has no fear of the criminal sanctions of the statute. However, his mere status as a licensed [589]*589physician who has been properly registered as a dispenser of the prohibited drugs does not give him the blanket right to abuse his authority and profession by dispensing drugs without relation to his sworn professional obligations.”
In State v Fearing, 30 Md App 134; 351 A2d 896 (1976), the Court reached the same conclusion.
We hold that physicians can dispense controlled substances only
"to the extent authorized by their registration and in conformity with the other provisions of this chapter.” MCL 335.332(2); MSA 18.1070(32)(2).
A physician dispensing controlled substances not in the course of professional practice or research can be prosecuted for unlawful delivery of a controlled substance. Whether a physician or any other person listed in MCL 335.307(3)(a); MSA 18.1070(7)(3)(a) is acting in good faith in the course of professional practice or research is a question of fact.7
V. Entrapment
This Court in People v Turner, 390 Mich 7; 210 NW2d 336 (1973), adopted the objective test for entrapment articulated by Justice Stewart’s dissenting opinion in United States v Russell, 411 US 423; 93 S Ct 1637; 36 L Ed 2d 366 (1973). This test focuses on
[590]*590"whether the actions of the police were so reprehensible under the circumstances, that the Court should refuse, as a matter of public policy, to permit a conviction to stand.” 390 Mich 7, 22.
The adoption of the objective standard does not automatically preclude the use of undercover agents, but only conduct so reprehensible that it cannot be condoned by the judicial system. After discussing the objective standard of entrapment, Justice Stewart noted in his dissent in Russell:
"This does not mean, of course, that the Government’s use of undercover activity, strategy, or deception is necessarily unlawful. Lewis v United States, 385 US 206, 208-209 [87 S Ct 424; 17 L Ed 2d 312] (1966). Indeed, many crimes, especially so-called victimless crimes, could not otherwise be detected. Thus, government agents may engage in conduct that is likely, when objectively considered, to afford a person ready and willing to commit the crime an opportunity to do so. Osborn v United States, 385 US 323, 331-332 [87 S Ct 429; 17 L Ed 2d 394] (1966). See also Sherman v United States [356 US 369, 383-384; 78 S Ct 819; 2 L Ed 2d 848 (1958)]. (Frankfurter, J., concurring).” 411 US 423, 445.
In People v D’Angelo, 401 Mich 167; 257 NW2d 655 (1977), we made it clear that
"[t]he policy considerations which moved us to adopt the objective test of entrapment compel with equal force the conclusion that the judge and not the jury must determine its existence. The thesis is that law enforcement conduct which essentially manufactures crime is a corruptive use of governmental authority which, when used to obtain a conviction, taints the judiciary which tolerates its use. It is a practice which relies for its success upon judicial indifference, if not approval, and it must be deterred. Its deterrence is a duty which transcends the determination of guilt or innocence in a given case and stands ultimately as the [591]*591responsibility of an incorruptible judiciary.” 401 Mich 167, 173-174.
In D’Angelo we also defined the burden of proof required and the standard to be used on review:
"We hold therefore that the defendant shall have the burden of proving the claim of entrapment by a preponderance of the evidence.
"The trial court’s finding will be subject to appellate review under the clearly erroneous standard.” 401 Mich 167, 183.
Defendant in this case failed to make a case of entrapment. Officer Kukalis did not attempt to create any special friendship with the doctor to facilitate a delivery of drugs. He did not cajole or induce the doctor to give him drugs. Officer Kukalis merely presented himself at the doctor’s office and asked for drugs, which he received. The conduct of the police in this case certainly did not approach the extreme situation we viewed in Turner. The undercover police officer in Turner worked for three years to establish a friendship with the defendant and then manufactured sad stories to obtain his sympathy.
The factual situation presented in the instant case does not reveal actions of the police so reprehensible that they should be excluded from the judicial administration of criminal justice.
We find as a matter of law that defendant was not entrapped.
V. Conclusion
We hold physicians are subject to prosecution under MCL 335.341; MSA 18.1070(41) for unlawful [592]*592delivery of a controlled substance when they are not within the authorization granted by their registration or in conformity with the other provisions of the act. A physician not acting in good faith in the course of professional practice or research is not in conformity with the other provisions of the act.
We find the defense of entrapment was not established.
The decision of the Court of Appeals is affirmed.
Coleman, C.J., and Fitzgerald and Ryan, JJ., concurred with Williams, J.